Ad
related to: cpi expected vs actual eps year price target for pfe stock
Search results
Results from the WOW.Com Content Network
The analyst anticipates that Pfizer’s management will guide to EPS in the mid-to-high $2 range with core business growth offset by the $0.30 in favorable but non-recurring items during 2024 ...
It now expects earnings per share between $2.15 and $2.35. That's up from previous guidance of between $2.05 and $2.25. That's up from previous guidance of between $2.05 and $2.25.
Pfizer (PFE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Pfizer (PFE) delivered earnings and revenue surprises of 21.09% and 7.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
The vaccination wave peaked earlier this year, and revenue/earnings are expected to drop in 2023.InvestorPlace - Stock Mark 3 Reasons Why It’s a Good Time to Buy PFE Stock Skip to main content
Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
For premium support please call: 800-290-4726 more ways to reach us
The drugmaker has been paying dividends consistently for over 85 years and has a five year dividend growth rate of 2.5%. It offers a dividend yield of around 6.1% at current levels, which is well ...
Ad
related to: cpi expected vs actual eps year price target for pfe stock